Improper activation of NF-κB implicates the development of chronic inflammation and cell death and is thought to be a therapeutic target for arthritis, though it plays a key role in activating the innate and adaptive immune system to protect against infection and promote survival [16, 17]. Here, NFKB1 is linked to arthritic joint disease.